NUCLEOLIN and neoplasm: Image analysis revealed significantly higher Ki-67 expression in tumor samples from mice co-treated with kallistatin and anti-nucleolin antibody, compared with those treated with kallistatin and nonimmune IgG antibody (Figure 8F, 8G).